オンコリスバイオファーマ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4588/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/11/18 | 日証協 | 1,020,970株 | +4.73% | 92,600株 | -28.11% | 740,180株 | +3.11% | 29,300株 | +19.11% |
2016/11/11 | 日証協 | 974,870株 | +1.79% | 128,800株 | +41.54% | 717,880株 | +1.67% | 24,600株 | -50.5% |
2016/11/04 | 日証協 | 957,770株 | +2.77% | 91,000株 | -45.87% | 706,080株 | +2.23% | 49,700株 | -21.24% |
2016/10/28 | 日証協 | 931,970株 | +3.72% | 168,100株 | +866.09% | 690,680株 | +7% | 63,100株 | +241.08% |
2016/10/21 | 日証協 | 898,570株 | -0.27% | 17,400株 | -59.35% | 645,480株 | -0.49% | 18,500株 | -19.23% |
2016/10/14 | 日証協 | 900,970株 | +0.12% | 42,800株 | -16.9% | 648,680株 | +2.25% | 22,905株 | -8.01% |
2016/10/07 | 日証協 | 899,875株 | -4.17% | 51,505株 | +159.21% | 634,380株 | -4.73% | 24,900株 | +120.35% |
2016/09/30 | 日証協 | 939,070株 | -1.4% | 19,870株 | -64.89% | 665,875株 | -0.37% | 11,300株 | -53.11% |
2016/09/23 | 日証協 | 952,400株 | -0.39% | 56,600株 | -9% | 668,375株 | -4.46% | 24,100株 | -30.13% |
2016/09/16 | 日証協 | 956,100株 | -2.1% | 62,200株 | -40.42% | 699,580株 | -1.92% | 34,495株 | +185.08% |
2016/09/09 | 日証協 | 976,600株 | -2.14% | 104,400株 | +57.94% | 713,280株 | -5.22% | 12,100株 | -87.68% |
2016/09/02 | 日証協 | 998,000株 | -4.08% | 66,100株 | -18.28% | 752,580株 | +2.65% | 98,200株 | +401.02% |
2016/08/26 | 日証協 | 1,040,500株 | -0.85% | 80,890株 | +133.79% | 733,180株 | +1.45% | 19,600株 | -27.68% |
2016/08/19 | 日証協 | 1,049,400株 | +0.23% | 34,600株 | +67.96% | 722,680株 | +0.42% | 27,100株 | +266.22% |
2016/08/12 | 日証協 | 1,047,000株 | +2.26% | 20,600株 | -85.53% | 719,681株 | +0.91% | 7,400株 | -76.51% |
2016/08/05 | 日証協 | 1,023,900株 | -1.64% | 142,400株 | +63.12% | 713,181株 | -0.78% | 31,507株 | -47.92% |
2016/07/29 | 日証協 | 1,041,000株 | -0.22% | 87,300株 | +70.84% | 718,774株 | -1.6% | 60,500株 | +300.66% |
2016/07/22 | 日証協 | 1,043,300株 | +5.01% | 51,100株 | -63.53% | 730,474株 | +2.63% | 15,100株 | -67.6% |
2016/07/15 | 日証協 | 993,500株 | +14.33% | 140,100株 | -33.25% | 711,774株 | -2% | 46,600株 | -60.51% |
※株式分割は考慮していませんのでご注意ください。
Page Top